Brief: Establishment Labs Holdings Inc - 2023 Rev guidance Of $200 mln To $210 mln, An Increase Of 24% To 30% Over 2022

Establishment Labs Holdings

27/02/2023 21:27

Feb 27 (Reuters) - Establishment Labs Holdings Inc
 ESTA.O :
    * ESTABLISHMENT LABS SUBMITS MODULE FOUR TO U.S. FDA FOR
PREMARKET
APPROVAL OF MOTIVA AND REPORTS RECORD FOURTH QUARTER AND FULL
YEAR 2022 FINANCIAL RESULTS
    * ESTABLISHMENT LABS HOLDINGS INC Q4 SALES $43.8 MILLION
    * ESTABLISHMENT LABS HOLDINGS INC - 2023 REVGUIDANCE OF $200
MILLION TO $210 MILLION, AN INCREASE OF 24% TO 30% OVER 2022
    * ESTABLISHMENT LABS HOLDINGS INC - MIA FEMTECH™
COMMERCIALIZATION
ON TRACK
    * ESTABLISHMENT LABS HOLDINGS INC - QTRLY LOSS PER SHARE
$0.55

Source text for Eikon:  ID:nBw2sK5bva 
Further company coverage:  ESTA.O 

 ((Reuters.Briefs@thomsonreuters.com;))